-
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets—PART 2: Approaches Beyond First-Line Therapy, and Novel Biologic Agents Under Investigation
Uncategorized
-
Genomic Findings Reshaping CRC Field
Uncategorized
-
Subtle molecular changes along the upper digestive tract could guide cancer therapy
Uncategorized
-
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Uncategorized
-
Deficiencies in Repair of DNA Identified in Many Types of Solid Tumors
Uncategorized
-
Will Adjuvant Oxaliplatin Data Change Practice in Colon Cancer?
Uncategorized
-
John Marshall, MD, and Qian Shi, PhD, on Colon Cancer: Results of the IDEA Trial
Uncategorized
-
John Marshall, MD, and John Neil Primrose, PhD, MBBS, on Biliary Tract Cancer: Results From the BILCAP Trial
Uncategorized
-
Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC
Uncategorized
-
The Biology of Extending Survival in Metastatic Colorectal Cancer
Uncategorized